AbbVie's menstrual migraine treatment meets late-stage study goal - Reuters
AbbVie's menstrual migraine treatment meets late-stage study goal Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxQd19JamxSNURwNmhhNjc0UDBuVmdhZ1VNR2FiMEgzZkV0WGR0bVJqNmN6eXV4bFZjYVN2czY1Qm5ib19jX1dwWUJRSjZqRlkyellQQV9iOUZ0N19XazJEX2tuQnRBaDBtanRxd1VHUWRJWHZJV3ZaenFUM3hBSjFFQUlVbWhvalpZRkNQaURWSVRzSnZEYjB4bXUxTFdLS29kbmViV1kzRTMtT21Lb3FNWHg1Ym1ycVhuT1V1NTR5eTRkVGVu?oc=5" target="_blank">AbbVie's menstrual migraine treatment meets late-stage study goal</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMAbbVie joins US government pilot to test drug discount rebates - Reuters
AbbVie joins US government pilot to test drug discount rebates Reuters
October 2, 2026 at 08:53 PMEndometriosis trial gives hope to millions of women in pain like me
A £2.3m study will look at whether a personalised pain management plan can improve the quality of life of women who have the debilitating condition.
September 30, 2026 at 05:21 AMUniQure plunges as Huntington's trial data disappoints investors - reuters.com
UniQure plunges as Huntington's trial data disappoints investors reuters.com
September 29, 2026 at 10:11 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMExperimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters
Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters
September 30, 2026 at 05:34 PM